The Catalyst in Omics and Genomics: Interview with Dr. Catalina Lopez-Correa, CSO and VP of Genome British Columbia
Columbia. Genome BC funds large-scale projects and platforms that work in the use and implementation of genomics. Scientific research and applications have strong support from both federal and provincial governments across Canada, and Genome BC is one of the provincial catalysts for this innovative science. Over the years, Genome BC has invested more than $850 million in genomics, and all life science areas.
Dr. Catalina Lopez-Correa, the Chief Scientific Officer (CSO) and Vice President, Sectors at Genome BC, has more than 20 years of experience in academic and private sectors in medicine and genomics, including the past two years with Genome BC. To learn more about how genomics is advancing in Canada, GeneOnline invited Dr. Lopez-Correa to an exclusive interview to share her professional insight.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02